Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.
How it described itself
Sepsis: Time Matters
Inflammatix is currently under construction. Coming soon!
All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.
How it describes itself
Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.
July 2026 – November 2026 · 2 captures · latest observed messagingTriage Transformed
Inflammatix is developing rapid point-of-care diagnostic tests by reading the immune response aimed to help physicians better diagnose acute infections and sepsis.
6 November 2026 · Triage Transformedcurrent websiteHistorical capture not publicly available
Seen July 2025 · 1 captureEmpowering emergency clinicians to rapidly recognize and act early on acute infections with unparalleled precision
Inflammatix is developing rapid point-of-care diagnostic tests by reading the immune response aimed to help physicians better diagnose acute infections and sepsis.
Seen July 2024 · 1 captureTesting designed to fit how emergency medicine physicians evaluate hard to diagnose patients
Inflammatix is developing rapid point-of-care diagnostic tests by reading the immune response aimed to help physicians better diagnose acute infections and sepsis.
7 January 2022 · READING THE IMMUNE SYSTEMarchived page
20 January 2023 · READING THE IMMUNE SYSTEMarchived page
March 2020 – January 2021 · 2 capturesHost-Response Diagnostics
We ‘read’ the immune system to characterize disease by measuring the expression levels of host genes and applying proprietary algorithms to produce results.
16 March 2020 · Host-Response Diagnosticsarchived page
14 January 2021 · Host-Response Diagnosticsarchived page
October 2016 – August 2018 · 3 capturesHostDx SEPSIS
We ‘read’ the immune system to characterize disease by measuring the expression levels of host genes and applying proprietary algorithms to produce results.